Related Experiment Video
Updated: Jul 13, 2026
13:57
Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
Laparoscopic bilateral adrenalectomy: results for 30 consecutive cases
M C Takata1, E Kebebew, O H Clark
1Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
Surgical Endoscopy
|July 12, 2007
Summary
Laparoscopic bilateral adrenalectomy is a safe and effective procedure for patients with Cushing's syndrome or pheochromocytoma. Postoperative recovery is generally short, with most patients discharged on hormone replacement therapy without complications.
Area of Science:
- Endocrinology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Adrenocorticotropin hormone (ACTH)-dependent Cushing's syndrome often necessitates bilateral adrenalectomy.
- Patients may experience severe debilitation due to chronic cortisol excess.
- This study evaluates laparoscopic bilateral adrenalectomy in such patients.
Purpose of the Study:
- To analyze the indications for laparoscopic bilateral adrenalectomy.
- To assess the safety and efficacy of the procedure.
- To determine postoperative outcomes in patients undergoing this surgery.
Main Methods:
- Retrospective review of 30 consecutive patients undergoing laparoscopic bilateral adrenalectomy (March 1996 - August 2006).
- Analysis of patient demographics, disease etiology, surgical approach, complications, length of stay (LOS), and follow-up.
- Data collected from a university tertiary referral center.
Main Results:
- Indications included refractory Cushing's disease (n=16), occult ectopic ACTH syndrome (n=9), and bilateral pheochromocytoma (n=5).
- No intraoperative complications occurred; 13% experienced postoperative complications.
- Mean postoperative LOS was 3.5 days; all patients received steroid replacement, with pheochromocytoma patients achieving biochemical cure.
Conclusions:
- Laparoscopic bilateral adrenalectomy demonstrates safety and effectiveness in a high-risk patient cohort.
- Close postoperative monitoring is essential.
- Patients are typically discharged with hormone replacement therapy shortly after surgery with minimal complications.
